Allspring Global Investments Holdings LLC decreased its position in The Cooper Companies, Inc. (NASDAQ:COO)

Allspring Global Investments Holdings LLC reduced its position in The Cooper Companies, Inc. (NASDAQ:COO – Free Report) by 1.7% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 9,862 shares of the medical device company’s stock after selling 170 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Cooper Companies were worth $861,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in the company. Franklin Resources Inc. raised its position in shares of Cooper Companies by 1.2% in the 4th quarter. Franklin Resources Inc. now owns 3,401 shares of the medical device company’s stock worth $1,287,000 after buying an additional 41 shares during the period. KLR Investment Advisors LLC boosted its stake in Cooper Companies by 4.3% in the fourth quarter. KLR Investment Advisors LLC now owns 1,117 shares of the medical device company’s stock worth $423,000 after acquiring an additional 46 shares in the last quarter. Quadrant Capital Group LLC boosted its holdings in Cooper Companies by 10.8% in the fourth quarter. Quadrant Capital Group LLC now owns 613 shares of the medical device company’s stock worth $232,000 after purchasing an additional 60 shares during the period. Westpac Banking Corp raised its stake in shares of Cooper Companies by 18.8% in the fourth quarter. Westpac Banking Corp now owns 543 shares of the medical device company’s stock valued at $205,000 after purchasing an additional 86 shares in the last quarter. Finally, Lincoln National Corp boosted its holdings in shares of Cooper Companies by 13.9% during the fourth quarter. Lincoln National Corp now owns 768 shares of the medical device company’s stock valued at $291,000 after purchasing an additional 94 shares in the last quarter. Institutional investors own 24.39% of the company’s shares.

Cooper Companies price performance

COO stock opened at $105.54 on Thursday. The firm has a market cap of $21.02 billion, a PE ratio of 61.99, a P/E/G ratio of 2.56 and a beta of 0.98. Cooper Companies, Inc. has a 1 year low of $75.93 and a 1 year high of $107.46. The company has a current ratio of 1.99, a quick ratio of 1.14, and a debt-to-equity ratio of 0.33. The firm has a fifty day simple moving average of $92.54 and a two hundred day simple moving average of $94.47.

Cooper Companies (NASDAQ:COO – Get Free Report ) last issued its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.05. The company had revenue of $1 billion during the quarter, compared to analysts’ expectations of $997.30 million. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. Cooper Companies’s revenue for the quarter was up 7.8% compared to the same quarter last year. In the same quarter last year, the company earned $0.84 per share. On average, equities analysts anticipate that The Cooper Companies, Inc. will post 3.66 EPS for the current year.

The Wall Street analyst weighs in

A number of research firms recently weighed in on COO. Stifel Nicolaus reaffirmed a “buy” rating and set a $115.00 price objective (up previously from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. Wells Fargo & Company upped their target price on Cooper Companies from $110.00 to $115.00 and gave the company an “overweight” rating in a report on Thursday, August 29th. Piper Sandler boosted their price target on shares of Cooper Companies from $115.00 to $120.00 and gave the stock an “overweight” rating in a research note on Thursday, August 29th. Jefferies Financial Group upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating and boosted their price objective for the company from $107.00 to $115.00 in a note of research on Tuesday, July 16. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research note on Thursday, August 29th. Four equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Moderate Buy” and an average target price of $113.61, according to MarketBeat.com.

See our latest stock analysis on Cooper companies

Cooper Companies Profile

(Free Report)

Cooper Companies, Inc, together with its subsidiaries, develops, manufactures and markets contact lens wearers. The company operates through two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lenses, including lenses that correct myopia and hyperopia; and toric and multifocal lenses comprising lenses that correct vision problems such as astigmatism, presbyopia and myopia in the Americas, Europe, the Middle East, Africa and Asia Pacific.

Featured stories

Want to see what other hedge funds own COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trading for The Cooper Companies, Inc. (NASDAQ:COO – Free Report).

Get daily news and ratings for Cooper companies – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Cooper Companies and related companies with MarketBeat.com’s FREE daily email newsletter.